Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neostigmine Reversal And Neuromuscular Recovery

NCT02433808 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT02433808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02433808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neostigmine Reversal And Neuromuscular Recovery
Lead sponsor
Endeavor Health
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2015
Completion date
April 30, 2017
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

residual neuromuscular block